Weight loss drug Belviq may increase risk of pancreatic, colorectal, and lung cancer

Posted
by Heygood Orr and Pearson

Last year, the FDA announced that studies showed that taking the weight loss drug Belviq may increase the risk of developing cancer.  In response to a request from the FDA, the drug’s manufacturer, Eisai Inc., agreed to pull Belviq off the market. 

The  FDA’s decision was based on results from a five-year study of Belviq users that the drug company had conducted.   According to the FDA,  Belviq (lorcaserin hydrochloride) and Belviq XR could be responsible for increased risk of developing a range of different cancers including pancreatic, colorectal, and lung cancer.   The study found that the greater incidence of cancer in users of Belviq increased the longer patients took Belviq. The FDA advised patients to discontinue use of the drug and to consult their physicians.

Belviq is a weight-loss drug that activates serotonin receptors in the brain to promote feelings of fullness and decrease food consumption. The drug had been approved by the FDA to help weight loss in adults who have health problems linked to excess weight, like diabetes, high blood pressure, and elevated cholesterol.

Pharmaceutical companies have a duty to make sure that their drugs are reasonably safe and to warn patients, doctors, and regulators about the known risks of taking a drug.   Drug companies

should thoroughly research the side effects of drugs such as Belviq before introducing them to the market.  

People who developed cancer, such as lung, pancreatic or colorectal cancer, after taking Belviq may be eligible to file a lawsuit against the drug company to help them cover the costs of medical expenses and other losses.  Those who lost a loved one to cancer after they took Belviq should also seek legal advice. 

Diagnosed with cancer after taking Belviq?

If you or a loved one have been diagnosed with cancer after taking the drug Belviq, contact Heygood, Orr & Pearson for your free case evaluation and to learn more about your legal right to compensation.

The lawyers at Heygood, Orr & Pearson have made it a career priority to hold drug and medical device manufacturers accountable and responsible for their actions.  From pharmaceutical liability cases involving the fentanyl pain patch or defective drugs such as Yaz and Yasmin, Actos, Avandia, and Accutane to lawsuits filed against the makers of defective hip and knee replacements and other medical devices, our law firm has made it a career priority to ensure that the makers of these dangerous products are held responsible in a court of law.

The attorneys at our firm have tried more than 200 cases to verdict. In total, our lawyers have achieved verdicts and settlements for our clients totaling more than $200 million. Our law firm is made up of trial lawyers in the truest sense of the phrase: we are as comfortable in front of a judge or jury as we are drafting legal briefs. Our named partners—Michael Heygood, Jim Orr, and Eric Pearson—have been named by their peers as Super Lawyers well over 10 years in a row, an honor given only to the top 5% of attorneys in Texas.

If you or a loved one has been injured by a defective drug or medical device, you have legal rights. For a free legal consultation about your case and to learn more about whether you may be eligible to file a lawsuit and seek compensation for your injuries, contact the lawyers at Heygood, Orr & Pearson. You can reach us by calling toll-free at 1-877-446-9001, or by following the link to our free case evaluation form.